AB
ORKA

Amalgamated Bank’s Oruka Therapeutics ORKA Stock Holding History

Amalgamated Bank’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,212
Closed -$37K – 2883
2025
Q4 		$37K Buy
1,212
+283
+30% +$7.88K ﹤0.01% 1913
2025
Q3 		$18K Hold
929
– – ﹤0.01% 2184
2025
Q2 		$10K Buy
+929
New +$9.68K ﹤0.01% 2452

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Amalgamated Bank's ORKA Position: Q1 2026 in Review

Amalgamated Bank sold out of Oruka Therapeutics (ORKA) in Q1 2026, closing a stake of 1,212 shares — an estimated $37K sold.

Amalgamated Bank first reported a position in ORKA in Q2 2025 and held it in 3 quarters. The position peaked at $37K in Q4 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Amalgamated Bank reported no remaining Oruka Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,212 Oruka Therapeutics shares in Q1 2026, an estimated $37K.
  • Amalgamated Bank first reported a position in Oruka Therapeutics in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's Oruka Therapeutics position peaked at $37K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.